Safety/Quality

Latest Issue of OR Manager
September 2024
Home Safety/Quality

UH Cleveland Medical Center awarded AHA Quest for Quality Prize

Editor's Note The American Hospital Association (AHA) will present this year’s Quest for Quality Prize to University Hospitals Cleveland Medical Center (UH) on July 18 at the AHA Leadership Summit in San Diego. UH is receiving the award because of its data-driven quality and safety improvements and innovative strategies to…

Read More

By: Judy Mathias
July 13, 2022
Share

Effectiveness of decontaminating PPE with methylene blue

Editor's Note This study led by researchers at the University of Washington, Seattle, finds that methylene blue with light (MBL) photochemical treatment can be used to decontaminate personal protective equipment (PPE) contaminated with COVID-19. MBL robustly and consistently inactivated three coronaviruses, including COVID-19, with 99.8% to >99.9% virus inactivation across…

Read More

By: Judy Mathias
July 12, 2022
Share

FDA: Class I recall of Getinge Flow-c, Flow-e Anesthesia Systems

Editor's Note The Food and Drug Administration (FDA) on July 6 identified the recall by Getinge USA Sales Inc of its Flow-c and Flow-e Anesthesia Systems as Class I, the most serious. The recall was initiated after reports of cracked or broken on/off switchs on the systems’ suction units. If…

Read More

By: Judy Mathias
July 12, 2022
Share

Wastewater provides early detection of COVID-19 variant transmission

Editor's Note Scientists at UC San Diego and Scripps Research have developed tools to analyze wastewater that have proven effective in identifying emerging COVID-19 variants and predicting surges. COVID-19 patients shed the virus in their stool, whether they have symptoms or not. In the summer of 2020 the scientists began…

Read More

By: Judy Mathias
July 12, 2022
Share

Sponsored Message

First cases of newest Omicron subvariant found in US

Editor's Note Three cases of the newest Omicron subvariant BA.2.75 have been detected on the West Coast, two in California and one in Washington, the July 11 Becker’s Hospital Review reports. The subvariant is also in India and 10 other countries. The subvariant has a large number of mutations that…

Read More

By: Judy Mathias
July 12, 2022
Share

Cancer screening decreased worldwide during COVID-19

Editor's Note This systematic review and meta-analysis from Stony Brook Cancer Center, Stony Brook University, New York City, and the University of Bologna, Bologna, Italy, finds that COVID-19 pandemic measures were associated with widely reduced cancer screening services. Between January and October 2020, there was an overall decrease of: -46.7%…

Read More

By: Judy Mathias
July 11, 2022
Share

Sponsored Message

Healthcare employment up in June

Editor's Note Overall healthcare employment in the US was up in June to a seasonally adjusted 16,314,900 workers, the Bureau of Labor Statistics reported on July 8. That’s up 56,700 since May. Hospital employment also was up by 20,500 jobs. The overall unemployment rate for June remained at 3.6%, for…

Read More

By: Judy Mathias
July 11, 2022
Share

The Joint Commission: New toolkit helps find survey, review resources

Editor's Note The Joint Commission, on July 6, announced a new online toolkit, the “Readiness Roadmap,” that will help organizations locate resources for survey or review based on where they are in their accreditation, certification, or verification process. The toolkit, which is available on The Joint Commission’s Connect extranet site…

Read More

By: Judy Mathias
July 11, 2022
Share

New study: Disposable gowns may expose clinicians to infection

Editor's Note After this October 2020 peer-reviewed study, titled “Disposable versus reusable medical gowns: A performance comparison,” found that “isolation gowns commonly worn in medical units or intensive care units ripped too easily and allowed about four to 14 times the expected amount of liquid to seep through when sprayed…

Read More

By: Tarsilla Moura
July 8, 2022
Share

FDA allows for pharmacists to prescribe Paxlovid to treat COVID-19

Editor's Note The US Food and Drug Administration (FDA) announced on July 6 that it would alter its emergency use authorization for the Paxlovid pill—Pfizer’s oral antiviral pill used by some to treat COVID-19—to allow pharmacists to prescribe the treatment to recently affected individuals directly. According to Fierce Pharma July…

Read More

By: Tarsilla Moura
July 8, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat